Company profile

Inspirata

Pathology & Laboratory Diagnostics

Company profile

About Inspirata

Inspirata is a leading oncology informatics company that provides end-to-end cancer registry automation solutions for healthcare organizations. With over 20 years of industry innovation, the company serves 270+ hospitals and processes more than 30 million pathology, radiology, and related clinical reports annually. Inspirata's flagship products, E-Path and E-Path Plus, leverage proprietary AI and Natural Language Processing (NLP) technology to automate the most time-intensive aspects of cancer registry management—casefinding and data abstraction. The platform identifies reportable cancer cases in real-time with 98-99% validated accuracy, reducing manual processing time from 30-45 minutes per report to seconds. E-Path Plus auto-populates abstracts with 124+ oncology-specific data elements directly from unstructured clinical documents, allowing oncology data specialists to focus on quality assurance rather than repetitive data entry. Through an exclusive partnership with ONCO, Inspirata delivers the industry's only unified workflow from initial clinical report to final state and federal submission. The company's solutions are deployed on-premises to ensure maximum security and HIPAA compliance, with seamless integration into major EHR, LIS, and RIS systems. Inspirata serves academic medical centers, comprehensive cancer centers, NCI-designated cancer centers, oncology departments, and community oncology practices. The platform addresses critical operational challenges including staffing shortages, registry backlogs, and accreditation requirements while unlocking cancer data for clinical research, trial matching, and patient navigation. With a 96% customer retention rate, Inspirata has established itself as the trusted partner for healthcare organizations seeking to transform their cancer registries from compliance burdens into strategic data assets that drive improved patient outcomes and operational efficiency.

Company description Inspirata official website

Primary marketPathology & Laboratory Diagnostics
Commercial modelCommercial information available on request
Company presenceLinkedIn X
Work at Inspirata?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • All reportable cancer types
  • Oncology across all sites and histologies
  • Tumor classification and staging

Who it serves

  • Academic Medical Centers
  • Community Oncology Practices
  • Comprehensive Cancer Centers
  • Hospital Oncology Departments
  • NCI-Designated Cancer Centers
  • State Cancer Registries

Deployment & integration

On Premise deployment with recorded integration context.

Recorded integration context: EHR systems, Hospital Information Systems (HIS), Laboratory Information Systems (LIS), ONCO registry software (exclusive partnership), ONCOLog registry management software, Radiology Information Systems (RIS).

Geographic context

MarketsUnited States
Company sourceOfficial website

Company milestones

Platform expansion

Exclusive partnership with ONCO to provide unified end-to-end cancer data platform combining Inspirata AI's technology with ONCO's registry software and services

Partnerships

Recorded partners

  • ONCO (exclusive partnership for end-to-end cancer data platform)

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

E-Path

Real-time automated cancer casefinding with 99% validated sensitivity

Software · On PremiseCompany source

E-Path Plus

Automated data abstraction extracting 124+ oncology-specific data elements

Software · On PremiseCompany source

NLP Engine

Proprietary AI/NLP engine for oncology data extraction and patient-trial matching

Platform · On PremiseCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Processing time reduction

From 30-45 minutes per report (manual) to seconds (automated)

Case identification accuracy

98-99% validated accuracy for reportable cancer case detection

Customer retention

96% customer retention rate

Data extraction

Auto-populates 124+ oncology-specific data elements

Victorian Cancer Registry

Improved casefinding completeness and contributed to more accurate and precise diagnosis and cancer classification

Greatly improved casefinding completeness

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Catherine Shang

Former Deputy Director of the Victorian Cancer Registry

06 · Company updates

Updates from Inspirata

Recent articles published on Inspirata's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Pathology & Laboratory Diagnostics

Companies applying AI to digital pathology, histopathology slide analysis, laboratory diagnostics, or biomarker discovery. Includes AI-powered interpretation of lab test results, at-home diagnostic devices with AI analysis, and platforms that analyze tissue samples or biological specimens to support clinical diagnosis.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon